INSULET CORPORATION

(PODD)
  Report
Delayed Nasdaq  -  05/19 04:00:01 pm EDT
194.74 USD   +2.48%
05/17Citigroup Adjusts Insulet's Price Target to $310 From $350, Reiterates Buy Rating
MT
05/06JPMorgan Adjusts Price Target for Insulet to $275 From $290, Maintains Overweight Rating
MT
05/06SVB Securities Adjusts Insulet's Price Target to $280 from $300, Keeps Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Berenberg Bank Adjusts Insulet's Price Target to $295 From $277, Maintains Hold Rating

11/08/2021 | 07:23am EDT


© MT Newswires 2021
All news about INSULET CORPORATION
05/17Citigroup Adjusts Insulet's Price Target to $310 From $350, Reiterates Buy Rating
MT
05/06JPMorgan Adjusts Price Target for Insulet to $275 From $290, Maintains Overweight Ratin..
MT
05/06SVB Securities Adjusts Insulet's Price Target to $280 from $300, Keeps Outperform Ratin..
MT
05/06INSULET CORP Management's Discussion and Analysis of Financial Condition and Results o..
AQ
05/06INSULET CORP : Change in Directors or Principal Officers, Other Events, Financial Statemen..
AQ
05/05Insulet Reports Q1 Profit , Names New CEO
MT
05/05Insulet Announces CEO Transition
BU
05/05TRANSCRIPT : Insulet Corporation, Q1 2022 Earnings Call, May 05, 2022
CI
05/05Insulet Corporation Announces Management Changes, Effective June 1, 2022
CI
05/05Insulet Corporation Announces Executive Changes, Effective June 1, 2022
CI
More news
Analyst Recommendations on INSULET CORPORATION
More recommendations
Financials (USD)
Sales 2022 1 233 M - -
Net income 2022 93,3 M - -
Net Debt 2022 207 M - -
P/E ratio 2022 147x
Yield 2022 -
Capitalization 13 503 M 13 503 M -
EV / Sales 2022 11,1x
EV / Sales 2023 9,09x
Nbr of Employees 2 300
Free-Float 99,5%
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 194,74 $
Average target price 272,25 $
Spread / Average Target 39,8%
EPS Revisions
Managers and Directors
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
INSULET CORPORATION-28.58%13 503
ABBOTT LABORATORIES-20.11%197 401
MEDTRONIC PLC-0.68%138 943
BECTON, DICKINSON AND COMPANY2.19%71 580
HOYA CORPORATION-25.01%36 535
BAXTER INTERNATIONAL INC.-15.42%36 314